Prognostic value of stress echocardiogram in patients with angiographically significant coronary artery disease. Am J Cardiol. 2012;109:153 8. 276. Shaw L, Cerqueira M, Brooks M, et al. Impact of left ventricular function and the extent of ischemia and scar by stress myocaridal perfusion imaging on prognosis and therapeutic risk reduction in diabetic patients with coronary artery disease: results from the Bypass Angioplasty Revascuarization Investigation 2 Diabetes (BARI 2D) Trial. J Nucl Cardiol. 2012. 277. Hachamovitch R, Rozanski A, Shaw LJ, et al. Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revasculariza- tion vs. medical therapy among patients undergoing stress-rest myo- cardial perfusion scintigraphy. Eur Heart J. 2011;32:1012 24. 278. Doesch C, Seeger A, Doering J, et al. Risk stratification by adenosine stress cardiac magnetic resonance in patients with coronary artery stenoses of intermediate angiographic severity. J Am Coll Cardiol Cardiovasc Imaging. 2009;2:424 33. Fihn et al Stable Ischemic Heart Disease: Full Text e441 279. Jahnke C, Nagel E, Gebker R, et al. Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobu- tamine stress wall motion imaging. Circulation. 2007;115:1769 76. 280. Bingham SE, Hachamovitch R. Incremental prognostic significance of combined cardiac magnetic resonance imaging, adenosine stress per- fusion, delayed enhancement, and left ventricular function over pre- imaging information for the prediction of adverse events. Circulation. 2011;123:1509 18. 281. Coelho-Filho OR, Seabra LF, Mongeon F-P. Stress Myocardial Per- fusion Imaging by CMR Provides Strong Prognostic Value to Cardiac Events Regardless of Patient s Sex. J Am Coll Cardiol Cardiovasc Imaging. 2011;4:850 61. 282. Kelle S, Chiribiri A, Vierecke J, et al. Long-term prognostic value of dobutamine stress CMR. J Am Coll Cardiol Cardiovasc Imaging. 2011;4:161 72. 283. Korosoglou G, Elhmidi Y, Steen H, et al. 